Cardio Conversations: 'Trials, Trials, Trials!' Volta Has Big Ambitions For AI In EP

In this edition of Cardio Conversations, Medtech Insight editor Reed Miller talked to Théophile Mohr Durdez, the CEO and co-founder of Volta Medical, a Marseille-based company applying artificial intelligence to electrophysiology. Volta has raised over €70m and is sponsoring the TAILORED AF trial to show that its software can make atrial fibrillation ablation more effective.

Cardio Conversations podcast by Medtech Insight
• Source: Citeline/Shutterstock

Volta Medical is investing in clinical trials to show its artificial intelligence (AI) software can improve the effectiveness of cardiac ablation in patients with persistent atrial fibrillation.

“Success rates for [ablation to treat] paroxysmal atrial fibrillation have been very good

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Cardio Conversations

More from Podcasts